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Abstract
Background: Major histocompatibility complex class I (MHCI) proteins present antigenic peptides for immune
surveillance and play critical roles in nervous system development and plasticity. Most MHCI are transmembrane
proteins. The extracellular domain of MHCI interacts with immunoreceptors, peptides, and co-receptors to mediate
immune signaling. While the cytoplasmic domain also plays important roles in endocytic trafficking, cross-presentation
of extracellularly derived antigens, and CTL priming, the molecular mediators of cytoplasmic signaling by MHCI remain
largely unknown.
Results: Here we show that the cytoplasmic domain of MHCI contains putative protein-protein interaction domains
known as PDZ (PSD95/disc large/zonula occludens-1) ligands. PDZ ligands are motifs that bind to PDZ domains to
organize and mediate signaling at cell-cell contacts. PDZ ligands are short, degenerate motifs, and are therefore
difficult to identify via sequence homology alone, but several lines of evidence suggest that putative PDZ ligand motifs
in MHCI are under positive selective pressure. Putative PDZ ligands are found in all of the 99 MHCI proteins examined
from diverse species, and are enriched in the cytoplasmic domain, where PDZ interactions occur. Both the position of
the PDZ ligand and the class of ligand motif are conserved across species, as well as among genes within a species.
Non-synonymous substitutions, when they occur, frequently preserve the motif. Of the many specific possible PDZ
ligand motifs, a handful are strikingly and selectively overrepresented in MHCI’s cytoplasmic domain, but not elsewhere
in the same proteins. Putative PDZ ligands in MHCI encompass conserved serine and tyrosine residues that are targets
of phosphorylation, a post-translational modification that can regulate PDZ interactions. Finally, proof-of-principle in
vitro interaction assays demonstrate that the cytoplasmic domains of particular MHCI proteins can bind directly and
specifically to PDZ1 and PDZ4&5 of MAGI-1, and identify a conserved PDZ ligand motif in the classical MHCI H2-K that
is required for this interaction.
Conclusions: These results identify cryptic protein interaction motifs in the cytoplasmic domain of MHCI. In so doing,
they suggest that the cytoplasmic domain of MHCI could participate in previously unsuspected PDZ mediated
protein-protein interactions at neuronal as well as immunological synapses.
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Background
The major histocompatibility complex class I (MHCI) is a
multi-gene family known for its roles in the immune re-
sponse. Classical MHCI proteins (HLA-A, −B, and –C in
humans; H2-K, −D, and –L in mice; Fig. 1a) present di-
verse peptides, derived primarily from cytosolic proteins,
for recognition by CD8+ cytotoxic T lymphocytes
(CTLs). In contrast, non-classical MHCI proteins
(HLA-E, −F, and –G in humans; members of the H2-
T, −Q, and -M gene clusters in mice) present more
specialized peptide or lipid repertoires, or are physic-
ally incapable of presenting antigen, and their func-
tions are relatively poorly understood.
In addition to MHCI’s well-known functions in the
immune response, recent studies have identified critical,
unexpected roles for MHCI in the establishment, func-
tion, and modification of neural circuits in the healthy
* Correspondence: lboulang@princeton.edu
1Department of Molecular Biology, Princeton University, Princeton, NJ 08544, USA
2Princeton Neuroscience Institute, Princeton University, Princeton, NJ 08544, USA
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Frietze et al. BMC Immunology  (2016) 17:24 
DOI 10.1186/s12865-016-0154-z
Fig. 1 MHCI gene family, and conservation of PDZ ligand motifs in MHCI cytoplasmic domains. a Greatly simplified schematic of the MHCI
genomic region in humans (HLA, on chromosome 6, top) and mice (H2, on chromosome 17, bottom), showing the relative positions of the
classical (black boxes) and non-classical (white boxes) MHCI genes or gene families. Multi-member gene clusters are indicated by breaks in the
chromosome. Numerous genes and pseudogenes have been omitted for clarity, and distances are not to scale. Centromeric is to the left.
Adapted from [62]. b Logo showing conservation of amino acids within closest-match homologues of the human classical MHCI HLA-A. The
height of each letter corresponds to the extent of conservation across species. Color code: ST, orange; YFWCMVILA, green; DE, red; all others black.
Below, individual source sequences. Putative PDZ ligand motifs are in red. Previously noted conserved serine and tyrosine residues that can be
phosphorylated in some species (underlined in bold in b and c; see text) are embedded in PDZ ligand motifs in several MHCI proteins. Similar
alignments have been performed previously (e.g., [15]). * = conserved; : = semi-conserved; . = similar. c Aligned amino acid sequences of the
cytoplasmic domains of human MHCI proteins, with putative PDZ ligand motifs highlighted (class 1PDZ ligand, orange; class 2, blue; class 3,
purple). Consensus motifs: class 1 PDZ, S/T-X-Y/F/W/C/M/V/I/L/A; class 2 PDZ, ΦXΦ (Y/F/W/C/M/V/I/L/A-X-Y/F/W/C/M/V/I/L/A); class 3 PDZ, D/E-X-
Y/F/W/C/M/V/I/L/A [49]. Human reference sequences obtained from NCBI, alignments performed using T-Coffee [34]. d Conservation of PDZ
ligands across human HLA genes from c, despite non-conservative substitutions. In two cases, a class 1 ligand motif is converted to class 2 by the
substitution (2), but remains a putative PDZ ligand. Color code as in (b)
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mammalian nervous system (reviewed in [1–4]). MHCI
limits synapse density in multiple brain regions [5–9],
limits hippocampal synaptic transmission mediated by
NMDA-type glutamate receptors (N-methyl D-aspartate
receptors [10]), and is required for normal NMDAR-
dependent synaptic plasticity and NMDAR- and hippo-
campus- dependent forms of learning and memory [11].
Despite the important roles of MHCI in determining
neuronal structure and function, the protein interactions
that mediate MHCI’s non-immune functions in neurons
have not been identified.
MHCI proteins are generally single pass transmem-
brane proteins comprised of an extracellular domain, a
transmembrane domain, and a short (~20–40 amino
acid) cytoplasmic domain. The extracellular domain of
MHCI binds to peptides, immunoreceptors and corecep-
tors to participate in immune surveillance. Although the
cytoplasmic domain is dispensable for MHCI delivery to
the cell surface and for effective presentation of en-
dogenous antigens in vitro [12, 13], subsequent studies
showed that the cytoplasmic domain regulates MHCI’s
endocytosis and delivery to the endoplasmic reticulum,
and is required for cross presentation of extracellularly
derived antigens [14–25]. MHCI’s cytoplasmic domain
also contains conserved serine and tyrosine residues,
some of which are phosphorylated in vitro and in vivo
[14, 15, 20, 26–34]. Despite this and other evidence sug-
gesting that the cytoplasmic domain of MHCI is func-
tionally important [17, 35–44], little is known about the
sequences or binding motifs that might mediate these
functions. As a result, the idea that MHCI might partici-
pate in cytoplasmic signaling remains controversial.
Here we identify potential mediators of cytoplasmic
signaling by MHCI: cryptic putative protein-protein
interaction motifs known as PDZ (PSD95, disc large, zo-
nula occludens-1) ligands. Multiple bioinformatic ana-
lyses suggest that PDZ ligand motifs in the cytoplasmic
domain of MHCI are under positive selective pressure,
and biochemical assays demonstrate that the cytoplas-
mic domain of MHCI can bind directly and specifically
to PDZ domains in vitro. These results reveal that
MHCI proteins may participate in PDZ interactions with
transmembrane or cytoplasmic proteins, and suggest a
possible mechanism by which MHCI could mediate
known and novel functions at both immunological and
neuronal synapses.
Results
PDZ ligand motifs are found in the cytoplasmic domain
of mouse and human MHCI proteins
Previous studies identified conserved tyrosine and serine
residues in the cytoplasmic domain of MHCI immune
proteins, some of which can be phosphorylated in vivo
and in vitro [14, 15, 20, 26–34], but the functional
importance of these conserved residues has remained
largely unknown. When examining the amino acid se-
quence of the human classical MHCI HLA-A, we found
that these conserved tyrosine and serine residues are
embedded in sequences that resemble PDZ ligands
(Fig. 1b).
PDZ ligands are short (~4 amino acid) motifs that
are recognized by larger (~80–90 amino acid) binding
pockets known as PDZ domains. PDZ domains are
found in more than 200 proteins in humans, and
have been identified in viruses, bacteria, yeast, plants,
and animals. PDZ interactions regulate protein
localization, binding specificity, and modification
(reviewed in [45]), and form the backbone of scaffolds
that organize diverse cell-cell contacts, including both
immunological and neuronal synapses (e.g., [46],
reviewed in [47]).
Most PDZ ligands characterized to date lie at the
extreme carboxy terminus (C-terminus) of transmem-
brane or cytosolic proteins. These C-terminal PDZ ligands
have been divided into classes, based on the properties of
the residues in specific positions in the ligand motif, al-
though the exact composition and number of consensus
motifs is a topic of ongoing research ([48–51]; Additional
file 1: Figure S1). In addition to C-terminal ligands, a
growing body of evidence supports the idea that PDZ
domains can bind to non-C-terminal (internal) ligands.
Indeed, internal PDZ ligands may be far more common
than previously appreciated [49, 52–61]. Although less
well-characterized than C-terminal ligands, internal PDZ
ligands might have similar consensus motifs, because
consensus properties for both C-terminal and internal
ligands will be dictated by the sterics and charge of the
PDZ domain binding pocket. In support of this possibility,
internal PDZ ligands identified in unbiased, high-
throughput yeast two-hybrid screens generally match the
requirements for C-terminal PDZ ligands for the same
PDZ domains [58].
We observed that the conserved serines in the cyto-
plasmic domain of HLA-A are embedded in two over-
lapping putative internal PDZ ligands: GSDV, a class 1
PDZ ligand motif (consensus motif [X S/T X Φ], where
X is any residue and Φ is hydrophobic) and DVSL, a
class 2 PDZ ligand motif (consensus motif [X Φ X Φ]
[49–51]). In addition, the conserved tyrosine is embed-
ded in a class 1 PDZ ligand motif, YTQA. To assess if
these motifs are under positive selective pressure, which
is a hallmark of functionally relevant motifs, we identi-
fied best-match homologues of human HLA-A in other
vertebrate species, using the online database search
STRING (http://string-db.org/; see Methods). Because
the MHCI gene region has undergone extensive duplica-
tion and deletion events over the course of vertebrate
evolution [62], it is difficult to identify true homologues
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(genes that descended from a common ancestral DNA
sequence) across species. Instead, sequences with the
highest amino acid sequence conservation were identi-
fied in as many species as possible, and aligned using T-
Coffee [63] (http://www.ebi.ac.uk/Tools/msa/tcoffee/).
Despite variation in the length of the cytoplasmic do-
main, significant conservation was seen throughout the
aligned sequences. All of the sequences have several
basic residues immediately adjacent to the hydrophobic
transmembrane region, a common feature of transmem-
brane proteins. These basic residues may interact with
the negatively charged phospholipid head groups at the
inner face of the membrane, and help prevent movement
of the protein perpendicular to the plane of the mem-
brane [64]. In addition, there was striking conservation
of several putative PDZ ligand motifs (Fig. 1b).
HLA-A is one of three classical MHCI genes in the
human genome, which also encodes several non-
classical MHCIs and MHCI-like proteins. Similarly, in
mice, there are three classical MHCI genes and several
non-classical MHCI genes (Fig. 1a). To determine if
other MHCI proteins also contain potential PDZ ligands,
we used a custom built MATLAB program to identify all
consensus motifs in the cytoplasmic domain of human
and mouse MHCI proteins. Full length amino acid se-
quences for seven human MHCIs and MHCI-like pro-
teins and 18 mouse MHCI proteins were obtained from
NCBI (National Center for Biotechnology Information),
and the cytoplasmic domains were identified using spli-
cing information, and aligned within species using T-
Coffee [63]. For this analysis, we used a relatively broad
categorization scheme to identify potential class 1 [(S/T)
X (Y/F/W/C/M/V/I/L/A)], class 2 [(Y/F/W/C/M/V/I/L/
A) X (Y/F/W/C/M/V/I/L/A)] and class 3 [(D/E) X (Y/F/
W/C/M/V/I/L/A)] PDZ ligands [49].
Several notable patterns emerged. First, the short cyto-
plasmic domains of nearly all of the MHCI proteins ex-
amined contain one or more putative PDZ ligands. Of
the seven human sequences examined, all but one
(HLA-G, which has the shortest cytoplasmic domain,
only six amino acids) contain at least one potential PDZ
ligand motif (Fig. 1c). Similarly, 16 of the 18 mouse cyto-
plasmic sequences examined contain one or more puta-
tive PDZ ligand motifs (Additional file 2: Figure S2).
Second, PDZ ligand motifs in the cytoplasmic domain of
MHCI do not appear to be randomly distributed. In-
stead, PDZ ligand motifs of a particular class (1, 2, or 3)
tend to occur at the same position. For example, five of
the six motif-containing human MHCIs contain a class
1 PDZ ligand motif at the same position in the align-
ment (for example, YTQA in HLA-A), while the sixth
MHCI has a class 2 ligand in this position (YVLA in
HLA-H; Fig. 1c). Third, the putative PDZ ligands in both
human and mouse MHCI encompassed the previously
observed conserved serine and tyrosine residues that are
targets of phosphorylation (Fig. 1b-c & Additional file 2:
Figure S2 [14, 15, 20, 26–34]). Fourth, some PDZ ligand
motifs overlapped with each other, either in pairs (for
example, HYVLA, which contains the overlapping class
2 PDZ ligand motifs HYVL and YVLA) or in longer
chains (for example, DVSLTACKV, which contains three
potential class 2 PDZ ligands, DVSL, SLTA, and ACKV).
Finally, while the exact amino acid sequence of PDZ lig-
and motifs in a given position was not perfectly con-
served, substitutions that occurred were frequently
conservative with respect to the PDZ ligand motif. For
example, all six motif-containing human MHCI proteins
have a PDZ ligand motif in the position where YTQA is
found in HLA-A (Fig. 1c), but only one amino acid in
the motif, A, was conserved across all six (Fig. 1d). Such
degeneracy is a hallmark of PDZ ligands, and may help
explain why these motifs were not identified as con-
served in MHCI proteins prior to the current study.
PDZ ligand motifs are enriched in the cytoplasmic
domain of MHCI proteins
One challenge of identifying short, degenerate motifs
based on sequence alone is that they are likely to occur at
a high frequency by chance. Thus the motifs we identified
in the cytoplasmic domain of MHCI may or may not be
true PDZ ligands. The fact that they occur in identical po-
sitions in multiple genes (Fig. 1b-c & Additional file 2:
Figure S2), and are conserved across species, despite
amino acid substitutions (Fig. 1d), supports the idea
that they have not occurred randomly. However, such
apparent conservation could also result from a recently
shared precursor and insufficient genetic drift, or could
be an allosteric structural requirement for other distant
motifs or functions. One prediction is that true PDZ li-
gands might be enriched in the cytoplasmic domain,
where PDZ interactions occur, and where PDZ ligands
could therefore be under positive selective pressure. To
evaluate this possibility, we used MATLAB to identify
all class 1 PDZ ligand motifs in the complete amino
acid sequence of 20 mouse MHCI and MHCI-like pro-
teins (see Methods for list), using the relatively restrict-
ive class 1 PDZ ligand consensus motif [X (S/T) X (V/
L)] [51]. All values were calculated as frequency of li-
gands per 100 amino acids, to control for the shorter
size of the cytoplasmic domain, and overlapping ligands
were counted as separate ligands. To establish a base-
line for how often these ligand motifs might arise by
chance in a given protein, the full amino acid sequence
of each protein was scrambled, and the same analysis
was performed.
We first compared the frequency of PDZ ligand mo-
tifs in the cytoplasmic versus extracellular domains,
since PDZ interactions are only known to occur in the
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cytoplasm. In the extracellular domain, the frequency
with which class 1 PDZ ligand motifs occurred was
comparable to what was seen in scrambled amino acid
sequences (~1 per 100 amino acids), consistent with
the idea that PDZ ligands are not selected for in the
extracellular space. In contrast, the number of PDZ
ligands observed in the cytoplasmic domain was
roughly three times this baseline value (Fig. 2a). The
significant enrichment of putative PDZ ligands in the
cytoplasmic domain of MHCI proteins suggests that
there is positive selective pressure on PDZ ligand
motifs specifically in the cellular context where PDZ
interactions occur.
One unusual set of MHCI-like proteins which may be
freed from this selective pressure is viral MHCI mimics.
These mimics have been adopted from host genomes,
Fig. 2 Enrichment of putative PDZ ligand motifs in the cytoplasmic domain of mouse MHCI proteins. a Frequency of the class 1 PDZ ligand
consensus motif [X (S/T) X (V/L)] [51] in the cytoplasmic domain (“CYTO”), extracellular domain (“EXTRA”) or scrambled full sequence (“SCRAM”) of
20 mouse MHCI and MHCI-like proteins (see Methods for list), represented as motifs per 100 amino acids. PDZ ligand motifs are enriched in the
cytoplasmic domain. Inset, frequency of PDZ ligand motifs in five viral MHCI mimics (UL-18, UL-37, UL-142, M144, and M153), which are likely to
be under different selective pressures than host MHCI. Axis labels in insets match those in main graph and are omitted for clarity. b Frequency of
inverted, non-functional class 1 PDZ ligand motifs [(V/L) X (S/T) X] in the same MHCI amino acid sequences. c PDZ ligand motifs in MHCI amino
acid sequences, represented in relation to the number of inverted motifs in the same domain. Inset, same data from the five viral MHCI mimics
used in (a). d Representation of four specific class 1 PDZ ligand consensus motifs (XSXV, XSXL, XTXV, XTXL) [51] in the extracellular (top) versus
cytoplasmic (bottom) domains of 99 MHCI proteins from 21 species. Serine-containing motifs are significantly over-represented relative to
threonine-containing motifs in the cytoplasmic domain. MHCI schematic, rcsb-pdb (http://pdb101.rcsb.org/motm/62). e–f Representation of
specific class 2 (ΦXΦ) and class 3 (X (D/E) X Φ) PDZ ligand motifs, respectively, where Φ = V/I/L/M/F/W/A/C. For a complete list of class 2 and class
3 ligands plotted and their frequencies, see Additional file 3: Figure S3. Color code is the same in both extracellular and cytoplasmic charts
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and can allow infected cells to evade NK cell-mediated
lysis after viral down regulation of endogenous host
MHCI, as part of the viral immuno-evasion strategy
[65–67]. Cytoplasmic signaling by these mimics in host
cells may not benefit the virus, and therefore may be lost
in rapidly evolving viruses. Consistent with this possibil-
ity, the cytoplasmic enrichment of PDZ ligand motifs is
completely abolished in viral MHCI mimics (Fig. 2a,
inset). These results together show that putative PDZ li-
gands are non-randomly distributed in MHCI proteins,
and are specifically enriched in the cellular compartment
in which PDZ interactions occur. These findings support
the idea that at least some of the PDZ ligand motifs in
the cytoplasmic domain of MHCI proteins are function-
ally relevant.
However, it is possible that the enrichment of these
short motifs in the cytoplasmic domain simply reflects a
cytoplasmic enrichment of the specific amino acids that
make up the consensus motifs, which would increase
the probability that they would occur there by chance.
To examine this possibility, we searched the same
mouse MHCI sequences for the same class 1 PDZ
ligand consensus motif [X (S/T) X (V/L)] [51], but
inverted the order of residues in the motif (for example,
instead of searching for XSXV, we searched for VXSX).
Importantly, inverted PDZ ligand motifs contain all of
the same amino acids as actual motifs, but are struc-
turally unsuited to bind in PDZ domain binding
pockets.
Unlike true PDZ ligand motif sequences, inverted
PDZ ligand motifs were not enriched in the cytoplas-
mic domain (Fig. 2b). Indeed, inverted motifs were
slightly less common in the cytoplasmic domain than
in the extracellular domain or in scrambled whole se-
quences. This may be because in the cytoplasmic do-
main, the relevant amino acids were often part of true
PDZ ligand motifs. To quantitatively assess the relative
distribution of forward versus inverted motifs, we cal-
culated the ratio of their occurrence in the cytoplasmic
and extracellular domains, as well as in scrambled se-
quences. In the cytoplasmic domain, where PDZ inter-
actions can occur, putative PDZ ligand motifs are more
than three times more common than inverted motifs
(Fig. 2c). In contrast, the ratio of forward to reverse
motifs was comparable in the extracellular domain and
in scrambled sequences. The enrichment of forward
over reverse motifs is also lost in the cytoplasmic
domain of viral MHCI mimics (Fig. 2c, inset). Thus the
enrichment of PDZ ligands in the cytoplasmic domain
(Fig. 2a) is not simply a consequence of more of the
necessary residues being present in this compartment.
Instead, PDZ ligand motifs in the cytoplasmic domain
of MHCI proteins appear to be under strong positive
selective pressure.
Specific PDZ ligand motifs are preferentially expressed in
the cytoplasmic domain of MHCI proteins
The preceding analyses made use of pooled data for
broadly defined putative class 1 PDZ ligand motifs [X
(S/T) X (V/L)] [51]. To obtain a more detailed picture of
the pressures on PDZ ligand sequences in the MHCI
cytoplasmic domain, we separately assessed the fre-
quency of occurrence of the specific class 1 PDZ ligand
motifs XSXV, XSXL, XTXV, and XTXL, which should
each represent roughly 25 % of the class 1 PDZ ligand
motifs, if they occur at random. To evaluate PDZ ligand
motif distribution in a larger dataset, we obtained full
length amino acid sequences for 99 MHCI or MHCI-
like proteins from 21 species, using the online database
STRING (http://string-db.org/) (see Methods). A custom
MATLAB program was used to identify specific putative
class 1 PDZ ligands in the cytoplasmic domains of these
99 MHCI proteins, as was done for mouse MHCIs
above.
All four class 1 PDZ ligand motifs were detected in
both domains of the MHCI proteins examined. However,
their relative frequencies differed widely in the two
compartments. In the extracellular domain, serine-
containing motifs represented 33 % of the total, and each
threonine-containing motif occurred at a nearly identical
frequency (XTXL, 34 %; XTXV, 33 %). In the cytoplas-
mic domain, however, there was a striking skewing of
the distribution (Fig. 2d). Serine-containing motifs
account for 88 % of the total motifs in the cytoplasmic
domain, while threonine-containing class 1 PDZ ligands
were rarely seen (XTXL, 7 % of the total; XTXV, 5 %).
Thus across many species, there is a strong overrepre-
sentation of serine-containing class 1 PDZ ligands, and
under-representation of threonine-containing motifs, in
the cytoplasmic domain but not in the extracellular
domain, further supporting the idea that the PDZ ligand
motifs in the cytoplasmic domain of MHCI are under
positive selective pressure.
A similar analysis was performed for class 2 PDZ
ligand motifs, using the consensus definition XΦXΦ,
where Φ = primarily hydrophobic residues (V, I, L, M, F,
W, or C) [51]. Likely because this highly degenerate
motif can be expressed as a very large number of specific
variants, some of the possible variants were never
observed in the small cytoplasmic domains. As with
class 1 PDZ ligand motifs, class 2 motifs in the extracel-
lular domain occurred at relatively random frequencies,
without a clear bias for any one motif. In striking con-
trast, a single motif, XVXL, comprised nearly a quarter
of the total class 2 PDZ ligand motifs observed in the
cytoplasmic domain (Fig. 2e). This enrichment is par-
ticularly remarkable given the large number of possible
class 2 PDZ ligands: XVXL represents only 2 % of the 49
possible degenerate class 2 PDZ ligand motifs [X
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(VILMFWC) X (VILMFWC)], but is more than ten
times more common than that in the cytoplasmic do-
main in this large, multi-species pool of MHCI proteins.
Similar analysis of class 3 PDZ ligand motifs [X (D/E) X
(VILMFWC)] also showed striking enrichment of one
motif, XDXA, in the cytoplasmic domain (Fig. 2f; for
a complete list of class 2 and 3 ligands plotted and
their frequencies, see Additional file 3: Figure S3).
Unlike class 1 and 2 ligands, however, class 3 ligands
also showed a bias in favor of a particular ligand in
the extracellular domain, although it was not the
same motif that was enriched in the cytoplasmic do-
main, and its enrichment was not as marked (XDXV
represented 32 % of the class 3 ligands in the extra-
cellular domain, as compared to XDXA’s 46 % in the
cytoplasmic domain). This may reflect pressure to
preserve extracellular XDXV sequences as part of a
common non-PDZ motif or structural element. Over-
all, these results suggest that specific PDZ ligand mo-
tifs are under strong positive selective pressure in the
cytoplasmic domain of MHCI proteins.
PDZ ligand motifs in the classical MHCI H2-Kb largely fall
within single exons
The cytoplasmic domain of MHCI proteins is relatively
short, ~25–40 amino acids in most cases. Despite this,
the cytoplasmic domain is encoded in 2–4 separate
exons, depending on the particular MHCI gene (exons
6, 7, and 8 in the classical MHCI H2-Kb; Fig. 3a). While
the reason for this fine division of the transcript remains
unknown, exons can in some cases represent distinct
functional modules [68]. Overlaying splicing information
from NCBI with putative PDZ ligand motifs revealed
that most of the motifs in H2-Kb are encoded in single
exons. Exon 6 encodes the overlapping ligand motifs
GDYA, DYAL, and YALA, exon 7 encodes the overlap-
ping ligand motifs TSDL and DLSL, and exon 8 encodes
the C-terminal motif HSLA. Only the overlapping motifs
DCKV and KVMV span an exon/intron boundary.
Notably, KVMV is also among the least conserved puta-
tive PDZ ligand motifs in H2-Kb, and is not detected in
this position in any other mouse MHCI examined
(Additional file 2: Figure S2).
Proof of principle: the cytoplasmic domains of MHCI
proteins can bind directly to recombinant PDZ domains
in vitro
The above analyses of amino acid sequence data suggest
that PDZ ligand motifs in the cytoplasmic domain of
MHCI proteins may be functionally important. To dir-
ectly test if the cytoplasmic domain of MHCI can engage
in PDZ interactions, we asked if recombinant MHCI
cytoplasmic domain peptides can bind to recombinant
PDZ domain peptides. Mouse H2-Kb was cloned from
C57BL/6 mouse hippocampus using the primers in
Additional file 4: Figure S4A. The cloned sequence was
verified by comparing to NCBI reference sequences be-
fore insertion into the pGTK vector. We then generated
a GST fusion protein with the last 42 amino acids of
H2-Kb (see Methods). This peptide comprises the
complete cytoplasmic domain of H2-Kb. Three different
lines of evidence were used to verify the identity of the
recombinant protein product. First, plasmids were
subjected to commercial sequencing. The returned
sequences were 100 % identical to the endogenous
sequence for H2-Kb, confirming that a correct insert was
introduced for in-frame expression of GST-tagged
H2-Kb cytoplasmic domain. Second, we performed mass
spectrometry on samples that contained either intact or
mutated GST-H2-Kb fusion peptides. These assays iden-
tified high levels of recombinant H2-Kb cytoplasmic
domain peptides, and similarly high levels of the associ-
ated GST tag. As expected, H2-Kb cytoplasmic domain
was not detected in vector-only controls, and peptides
with point mutations (see below) differed from intact
H2-Kb peptide only at the mutated residue. Diagnostic
spectra are shown in Additional file 4: Figure S4B-C.
This peptide sequence data indicates that the encoded
peptides are correctly expressed. Third, purified recom-
binant MHCI cytoplasmic domain peptides were sub-
jected to SDS-PAGE and western blotting using an
antibody raised against the final exon (exon 8) in the
cytoplasmic domain of mouse H2-Kb. A band of the
appropriate size is detected in Western blots (Additional
file 4: Figure S4D). Thus three independent measures all
support the conclusion that the recombinant peptide we
produce is a GST-tagged version of the cytoplasmic
domain of the classical MHCI H2-Kb. This GST fusion
protein was used to screen PDZ domains that were
expressed as His-tagged fusion proteins, purified, and
spotted in equal amounts onto nylon membranes. PDZ
domains are discrete structural units that can fold prop-
erly when expressed as isolated peptides, and display
native binding preferences in in vitro binding assays
[69–72]. Therefore this type of biochemical array has
been used in previous studies to identify proteins that
can bind directly to a variety of PDZ domains (e.g., [70]).
In a proof-of-principle analysis, we probed the binding
of recombinant, MHCI-derived peptides to PDZ do-
mains from two proteins: MAGI-1 (Membrane-associ-
ated guanylate kinase, WW and PDZ domain-containing
protein 1), a multi-PDZ domain synaptic scaffolding pro-
tein that interacts with NMDA receptors and is required
for specific aspects of associative learning and memory
[73–75], and SAP-97 (synapse-associated protein 97, also
known as DLG1), which regulates NMDAR trafficking
[76–79]. These PDZ domains were of particular interest
because MHCI regulates NMDA receptor-mediated
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Fig. 3 (See legend on next page.)
Frietze et al. BMC Immunology  (2016) 17:24 Page 8 of 18
synaptic transmission and plasticity [10, 11], but the
mechanisms by which MHCI regulates NMDARs remain
unknown. Membranes were spotted with recombinant
PDZ domains and then incubated with recombinant
GST-tagged MHCI cytoplasmic domains (Fig. 3b). After
extensive washing, robust detection of GST revealed that
the cytoplasmic domain of H2-Kb bound directly and
specifically to PDZ1 of MAGI-1, and less intensely to
PDZ4+5 (Fig. 3c), but not to any PDZ domain of SAP97
(Fig. 3d). The specificity of the interaction for only cer-
tain PDZ domains suggests it does not simply reflect
nonspecific binding between recombinant peptides. The
specificity of the interaction is also supported by two
other observations: (1) the interaction is absent in GST-
only (no MHCI C-tail) controls, and (2) the interaction
declines in direct relation to the concentration of MHCI
cytoplasmic domain peptides present (Additional file 4:
Figure S4E-F). In addition, a single point mutation in the
MHCI peptide is sufficient to abolish binding (see
below), further supporting the idea that these interac-
tions are not a consequence of nonspecific binding, but
represent a real and specific interaction between the
cytoplasmic domain of MHCI and particular PDZ
domains.
MAGI-1 PDZ1 binds to class 1 PDZ ligands in other
proteins which conform to the consensus motif [X –S/T –
X –V/L] [80–82]. The cytoplasmic domain of the classical
MHCI H2-Kb, which we find can bind directly to PDZ1 of
MAGI-1, contains a single sequence that conforms to this
class 1 PDZ ligand motif: TSDL. Several other MHCI pro-
teins contain sequences that conform to this motif in an
identical or similar position in amino acid sequence align-
ments (Fig. 3f). For example, the nonclassical MHCI H2-
T22 contains the putative class 1 PDZ ligand KTVV, and
we find that H2-T22, like H2-Kb, can bind directly to
MAGI-1 PDZ1, but not PDZ 2 or 3, in vitro (Fig. 3e). In
contrast, the closely-related MHCI H2-T23, which lacks a
class 1 PDZ ligand motif (Fig. 3f), also fails to bind
MAGI-1 PDZ1 in our in vitro binding assay (Fig. 3e).
Similarly, the other classical MHCI found in C57BL/6
mice, H2-D, does not contain a putative PDZ ligand that
fits this motif (Fig. 3f), and does not appear to bind signifi-
cantly to MAGI-1 (Fig. 3g). Thus the presence of a class 1
PDZ ligand correlates with the ability of particular MHCI
cytoplasmic domains to bind directly and specifically to
PDZ1 of MAGI-1.
One prediction, if H2-K and H2-T22 both bind dir-
ectly and specifically to PDZ1 of MAGI-1, is that bind-
ing of one MHCI to MAGI-1 should be competed away
by preincubation with the other. To test this prediction,
MAGI-1 PDZ1 peptides were bound to a column, and
preincubated with cytoplasmic domain peptides from
either H2-T22, which binds to MAGI-1 PDZ1, or H2-D,
which does not (Fig. 3e). Other columns were preincu-
bated in buffer, as a control. After extensive washing
(see Methods), the same columns were incubated in H2-
K-derived cytoplasmic domain peptides. Preincubation
with H2-T22, but not H2-D, completely abolished H2-
K’s ability to bind to MAGI-1 PDZ1 (Fig. 3g). This result
suggests that the cytoplasmic domains of H2-K and H2-
T22 are competing for occupation of the same site on
MAGI-1 PDZ1, as would be expected for a classical
PDZ interaction.
To directly test if the class 1 PDZ ligand motif TSDL
is necessary for binding to MAGI-1, we eliminated this
motif in H2-Kb, by mutating a key residue in the motif
(T329A; TSDL->ASDL). Strikingly, this single point mu-
tation is sufficient to disrupt the direct interaction
(See figure on previous page.)
Fig. 3 MHCI can bind directly to PDZ domains in vitro. a Schematic showing the exons that encode the classical MHCI H2-Kb. A signal sequence
(S) is followed by exons encoding the three extracellular alpha domains, a single exon encoding the transmembrane domain, and three exons (6,
7, and 8) encoding the intracellular domain (not drawn to scale). Bottom, amino acid sequence of exons 6, 7, and 8 in H2-Kb. Putative PDZ ligand
motifs are underlined. Exon 6 encodes the overlapping ligand motifs GDYA, DYAL, and YALA, exon 7 encodes the overlapping ligand motifs TSDL
and DLSL, and exon 8 encodes the C-terminal motif HSLA. Only the overlapping motifs DCKV and KVMV span an exon/intron boundary. Notably,
KVMV is also among the least conserved putative PDZ ligand motifs in H2-Kb, since it is not detected in this position in any other mouse MHCI.
Intronic structure, NCBI. Adapted from [15]. b Schematic of in vitro binding assay. Different recombinant PDZ domain peptides are bound to each
membrane spot, and the membrane is panned with GST-tagged recombinant cytoplasmic domains from specific MHCI proteins. A direct interaction
between the cytoplasmic domain of MHCI and a given PDZ domain will be apparent as a black spot after visualization of bound anti-GST antibodies.
c The cytoplasmic domain of the classical MHCI H2-Kb can bind directly to PDZ1 and to a lesser extent PDZ4+5 of MAGI-1, but not to PDZs 2 or 3 of
the same protein. See Additional file 4: Figure S4B&D for validation of the identity of H2-K peptides, and S4E-F for titration of H2-Kb binding. d The
cytoplasmic domain of the classical MHCI H2-Kb does not bind to PDZ1+2 (expressed together) or PDZ 3 of SAP97. e MAGI-1 binding by recombinant
cytoplasmic domains derived from different classical and nonclassical MHCI proteins. Notably, the ability to bind to PDZ1 of MAGI-1 correlates with the
presence of a class 1 PDZ ligand motif, which is present in H2-Kb and H2-T22, but not H2-D or H2-T23 (see f). f Amino acid sequences of the
cytoplasmic domains of mouse and human MHCIs, aligned in ClustalW. Highlighted, putative class 1 PDZ ligand motifs (consensus [X – S/T –
X – V/L]) that match MAGI-1 PDZ1’s binding preferences [80–82]. g Competition assays show that preincubation of column-bound MAGI-1
PDZ1 with cytoplasmic peptides derived from H2-T22, which can bind, but not H2-D, which cannot, precludes subsequent binding by peptides
derived from H2-K. Left, pure H2-K not applied to a column; “none”, preincubation in buffer alone. H2-K was detected using an antibody against the
cytoplasmic domain of H2-K (see Methods). Bottom, anti-His antibody shows eluted MAGI-1 peptide (arrow). h A point mutation in the lone class 1
PDZ ligand motif, TSDL, in the cytoplasmic domain of H2-Kb attenuates binding to MAGI-1 PDZ1. The location of the mutated residue (T329) is shown
in (a)
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between the cytoplasmic domain of H2-Kb and PDZ1
and PDZ4&5 of MAGI-1 in vitro (Fig. 3h). Together,
these results provide the first evidence that the cytoplas-
mic domain of MHCI can bind directly and specifically
to PDZ domains.
Discussion
Here we show, for the first time, that the cytoplasmic do-
main of MHCI contains conserved PDZ ligand motifs and
can engage in PDZ interactions in vitro. Several lines of
evidence suggest that PDZ ligand motifs in the cytoplas-
mic domain of MHCI are under positive selective pres-
sure. The PDZ ligand motifs are conserved across species,
with occasional non-synonymous mutations that still pre-
serve the motif, and are found in consistent positions in
the sequences of multiple members of the large MHCI
gene family in diverse mammalian species. These motifs
are enriched in the cytoplasmic domain, where PDZ inter-
actions occur, despite the lack of amino acid bias to ex-
plain this enrichment, and tend to be encoded in single
exons. The cytoplasmic enrichment of PDZ ligand motifs
is lost in viral MHCI mimics, which evolve rapidly and
may no longer be under selective pressure to perform cell-
autonomous signaling in host cells. Specific motifs are sig-
nificantly overrepresented in the cytoplasmic domain, in
contrast to the extracellular domain, where the possible
motifs appear to occur more randomly. Finally, proof-of-
concept experiments demonstrate that the cytoplasmic
domain of MHCI can bind directly and specifically to
PDZ1 and PDZ4&5 of MAGI-1 in vitro, an interaction
that requires a conserved class 1 PDZ ligand that is specif-
ically found in MHCIs that can bind to MAGI-1. To-
gether, these results suggest that MHCI may participate in
previously unsuspected cytoplasmic signaling mediated by
PDZ interactions.
Putative PDZ ligand motifs are conserved in MHCI
proteins from 13 species (Fig. 1b). The position of the
motifs, their class, and even their exact amino acid se-
quence are well conserved. This conservation is particu-
larly remarkable given that exact orthologues of most
MHCI genes are difficult to determine in other species,
due to frequent addition and loss of genes [62]. Thus the
conservation of PDZ ligand motifs noted here, while
striking, is still likely an underestimate of the actual con-
servation across true orthologues. In addition, the MHCI
region exhibits a relatively high rate of genetic change
over evolutionary time, and overall amino acid sequence
conservation is low among MHCI genes from different
species. In the face of this high genetic variability, it ap-
pears that strong evolutionary pressures have actively
conserved PDZ ligand motifs in the cytoplasmic domain
of MHCI proteins.
Conservation of PDZ ligand motifs among genes
within a species is also striking. Human HLA-A, −B, −C,
−D, and –F all show similar patterns of ligand motifs
(Fig. 1c). In mouse, where the MHCI gene family is lar-
ger, there appeared to be groups of genes that form clus-
ters of conservation (Additional file 2: Figure S2; for
example, H2-K, −D, −L, −Q1, and –Q2 form one cluster,
H2-T3-7; H2-T9-10 form another). These may reflect a
common origin for members of that cluster, and/or
functional specialization of certain sets of genes. Non-
synonymous substitutions that preserve PDZ ligands in
specific positions (see examples in Fig. 1d & Additional
file 2: Figure S2) may influence the specificity or dynam-
ics of interactions at that site, while still preserving their
ability to engage in PDZ interactions.
The bulk of the PDZ ligands identified to date are in
the extreme carboxy-terminus of transmembrane or
cytosolic proteins, in part because the C-terminus has
been considered part of the consensus in most searches
to identify new ligands. However, a growing body of evi-
dence supports the idea that PDZ domains also com-
monly bind internal ligands [49, 52–61]. Studies
comparing internal and C-terminal ligand preferences of
specific PDZ domains using high-throughput methods
suggest that C-terminal and internal ligands share key
features [58], likely because they must both conform to
the constraints of the same PDZ binding pocket. Thus
current definitions of PDZ ligand motifs, while derived
primarily from known and predicted C-terminal ligands,
are a valid starting point from which to identify potential
novel internal PDZ ligands.
PDZ ligand motifs are defined by short, degenerate
consensus sequences, and therefore are likely to occur
by chance. This property of ligands may make it rela-
tively easy for new PDZ interactions to arise during evo-
lution, but poses a significant barrier to identifying new
internal ligands using sequence information alone. In
this study, several independent analyses were used to as-
sess the probability that PDZ ligands in the MHCI cyto-
plasmic domain arose by chance. These analyses
consistently support the idea that at least some of the
PDZ ligands in the cytoplasmic domain of MHCI are
under positive selective pressure. The degeneracy of
PDZ ligand motifs, and the assumption that they are ex-
clusively C-terminal, as well as the relatively recent dis-
covery of PDZ interactions [83], all likely contributed to
these important motifs in MHCI not being identified
previously. A previous study noted a structural feature
of unknown importance that is shared by proteins that
undergo endocytosis via coated pits, including HLA-A,
which they defined as [(aromatic: F, W, G or Y) (polar:
Q, S, or T) (charged: D, E, K, R, or S) (hydrophobic: V, I,
L, M, P, or T) (not hydrophobic)] [18]. Importantly, this
structural feature encompasses one of the most highly-
conserved PDZ ligand motifs (GSDV) we identified in
HLA-A (Fig. 1b).
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Several independent lines of evidence suggest that the
direct interactions between the cytoplasmic domain of
the classical MHCI H2-K and PDZ1 of MAGI-1 we re-
port here are not a consequence of nonspecific binding,
but represent a real and specific interaction between the
cytoplasmic domain of MHCI and particular PDZ pro-
teins. H2-K does not bind to all of the eight PDZ do-
mains from two different proteins tested, but rather
binds specifically to PDZ1 and PDZ4+5 of MAGI-1. The
H2-K cytoplasmic domains are GST-tagged for detection
and purification purposes, but GST alone does not bind
to any of the PDZ domains tested, suggesting that any
binding is due to residues in H2-K. Binding is
concentration-dependent with respect to the level of
H2-K present, and can be competed away by preincuba-
tion of PDZ1 of MAGI-1 with peptides derived from an-
other MHCI that binds to MAGI-1 in vitro. Finally,
binding to MAGI-1 PDZ1 correlates with the presence
of a class 1 PDZ ligand, and a single point mutation that
disrupts this motif also abolishes H2-K’s ability to bind
to MAGI-1 PDZ1. Notably, the fact that a lone point
mutation abolishes binding serves as a more powerful
negative control for nonspecific binding than either a
scrambled or irrelevant peptide, because it differs at only
a single amino acid. Together, these results strongly sup-
port the idea that the cytoplasmic domain of H2-K, and
likely other MHCI proteins including H2-T22, can par-
ticipate in direct, specific PDZ interactions.
The cytoplasmic domain of MHCI is essential for
normal endocytic trafficking of MHCI and subsequent
cross presentation of extracellularly derived antigens
[14–24]. In particular, a putative tyrosine-based endo-
cytic motif, YXXA, has been implicated in the control
of MHCI endocytic trafficking [14, 15, 25]. Of note,
YXXA is a class 1 or class 2 PDZ ligand motif in most
MHCIs (Fig. 1b-d and Additional file 2: Figure S2). The
cytoplasmic domain forms a macromolecular complex
with the vesicular trafficking protein Sec23a in the
trans-golgi network [17], and may interact with cyto-
skeletal proteins [41–43]. Several studies over the past
three decades have suggested that MHCI may mediate
reverse signaling [35–40], but cytoplasmic signaling by
MHCI remains controversial, in part because the mo-
lecular mediators are largely unknown. The current re-
sults raise the possibility that these and other functions
of MHCI involve PDZ interactions with transmem-
brane or cytoplasmic proteins. The cytoplasmic domain
of MHCI is phosphorylated in vitro and in vivo at mul-
tiple sites, including Y320 of HLA-A and S335 of HLA-
B [20, 26, 27, 29, 30], sites that we find are embedded
in PDZ ligand motifs (Fig. 1b-c and Additional file 2:
Figure S2). It will be of interest to determine if phos-
phorylation of these residues in the MHCI cytoplasmic
domain modifies their ability to participate in PDZ
interactions, as has been seen with other PDZ ligands
([84]; reviewed in [85]).
The intron/exon structure of the MHCI cytoplasmic
domain is notable: in H2-Kb, three micro-exons (exons
6, 7, and 8) together encode a polypeptide segment of
only ~40 amino acids [86, 87], hinting that the cytoplas-
mic domain of MHCI may be composed of distinct
structural and/or functional modules. Consistent with
this possibility, we find that PDZ ligand motifs in the
cytoplasmic domain largely fall within single exons
(Fig. 3a). There are at least 12 splice variants of the
mouse classical MHCI H2-K deposited in NCBI to date,
and the cytoplasmic domain is alternatively spliced in all
of them. Furthermore, alternative splicing that removes
exon 7, the site of a highly-conserved PDZ ligand motif
(Figs. 1b and 3), has been observed in many species, in-
cluding humans [16, 28, 88–90]. Loss of exon 7 is asso-
ciated with enhanced anti-viral CTL responses in vivo
[15], and is associated with slower internalization of
MHCI from the cell surface [18]. The current results
suggest that alternative splicing could potentially regu-
late MHCI’s ability to participate in PDZ interactions,
for example, in specific tissues and developmental stages
or in disease states.
One key feature of internal PDZ ligands is that they
must adopt an appropriate conformation to fit into the
pocket of the PDZ domain binding groove. Some in-
ternal ligands are deformed by interaction with the PDZ
domain pocket, allowing the peptide to extend past the
end of the pocket [60]. Others form a β-finger, which
acts as a pseudo-C-terminus [59, 91, 92]. The cytoplas-
mic domain of MHCI is predicted to be unstructured,
but could potentially form a β-finger through interaction
with other proteins. Consistent with this possibility,
crystal structures show that the cytoplasmic domain of
MHCI is deformed into a tight turn by the HIV protein
Nef [93]. Palmitoylation of MHCI [94] may also intro-
duce a kink in the cytoplasmic domain, potentially facili-
tating interactions with PDZ domain pockets. The
conservation of sequences immediately flanking the PDZ
ligand motifs in MHCI (Fig. 1b) may reflect an import-
ant role for these flanking residues in ensuring that PDZ
ligand motifs are presented in the appropriate context
for recognition by PDZ domains.
How could PDZ interactions contribute to MHCI
function in vivo? Several theories remain to be ex-
plored. PDZ interactions could contribute to the traf-
ficking and/or clustering of MHC proteins, or could
transduce signals from the extracellular domain.
MHCIs are among the most polymorphic genes in
the human genome, with thousands of variants se-
quenced to date. In-depth future studies will be
needed to fully profile the binding of all of the differ-
ent MHCI proteins and variants to the hundreds of
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different PDZ domains that have been identified in
mammals, to determine if the identified interactions
are of sufficient strength and specificity to occur in
cells, and to characterize the functional significance of
these interactions in specific biological contexts. The
relative invariance of the cytoplasmic domain across
human HLA variants means it is particularly well-
suited to mediating aspects of MHC function where
allelic variability is less beneficial, for example, in
organization of the immunological synapse, or in the
non-immune functions of MHCI in the brain
(reviewed in [1–4]). PDZ interactions are common at
cell-cell junctions, including neuronal and immuno-
logical synapses. The current results suggest that
MHCI-mediated PDZ interactions could play a central
role in immune signaling, and could also contribute
to the newly discovered functions of MHCI in the
healthy developing and adult nervous system.
Conclusions
These results identify cryptic PDZ-based protein inter-
action motifs in the cytoplasmic domain of MHCI. Mul-
tiple bioinformatic analyses suggest that PDZ ligand
motifs in the cytoplasmic domain of MHCI are under
positive selective pressure, and biochemical assays dem-
onstrate that the cytoplasmic domain of MHCI can bind
directly and specifically to PDZ domains in vitro. These
results identify a mechanism by which MHCI proteins
may bind directly to transmembrane or cytoplasmic pro-
teins, and suggest that MHCI could mediate previously




Mouse and human MHCI amino acid sequences were
obtained from the National Center for Biotechnology
Information (NCBI) Protein Database (http://www.
ncbi.nlm.nih.gov/protein). For human MHCI (HLA)
genes, for which thousands of variants have been se-
quenced to date, the reference allele was used (https://
www.ebi.ac.uk/ipd/imgt/hla/). Mouse MHCI (H2)
sequences were all from the b haplotype, except H2-L,
which is not present in the b haplotype, and therefore
the d haplotype allele was used.
To obtain full length amino acid sequences for MHCI
proteins from other species, STRING version 10 was
used (http://string-db.org/) [95]. Entering a given mouse
or human MHCI gene name, and using the “Occur-
rence” function, yielded complete amino acid sequences
for the closest-match homologues of that gene in other
species. A series of 14 distinct mouse and human MHCI
and MHCI-like proteins were searched in STRING
(mouse H2-K, −D, −T5, −M5, −T9, FcRn, and HFE;
human HLA-A, −B, −C, −E, −G,–H (HFE), and FcRn),
and all redundant sequences (those identified in more
than one search) were discarded to avoid oversampling
bias. This strategy produced a set of 99 non-redundant
MHCI amino acid sequences from 21 species. Other
searches were performed, but not included, because all
products of the search were redundant with those identi-
fied in previous searches. Amino acid sequences for viral
MHCI mimics (UL-18, UL-37, UL-142, M144, and
M153) were also obtained from NCBI.
The location of the cytoplasmic domain of each amino
acid sequence was identified by splicing information, hydro-
phobicity, or alignment with other sequences, or predicted
using TOPCONS (http://topcons.cbr.su.se/) and manually
curated. To randomize full amino acid sequences of mouse
MHCIs for Fig. 2a-c, a free online text scrambler (http://
textmechanic.com/Word-Scrambler.html) was used.
Multiple sequence alignments
Full sequences were aligned using ClustalOmega (http://
www.ebi.ac.uk/Tools/msa/clustalo/) [96], and cytoplasmic
domain sequences were aligned using T-Coffee (http://
www.ebi.ac.uk/Tools/msa/tcoffee/) [63], both allowing gaps.
Matlab code
A custom-built MATLAB script (MATLAB version
7.10.0.499, The Mathworks, Inc., Natick, MA) was used
to identify putative PDZ ligand motifs in MHCI cyto-
plasmic domain sequences. PDZ ligand consensus motifs
used in Fig. 1 and Additional file 2: Figure S2: class 1,
[(S/T) X (Y/F/W/C/M/V/I/L/A)], where X is any amino
acid; class 2, [(Y/F/W/C/M/V/I/L/A) X (Y/F/W/C/M/V/
I/L/A)]; class 3, [(D/E) X (Y/F/W/C/M/V/I/L/A)] [49].
For Fig. 2a–c, PDZ ligand consensus motifs were: class
2, [X Φ X Φ], and class 3, [X (D/E) X Φ], where is Φ de-
fined as V/I/L/M/F/W/C, and X is any amino acid. All
MATLAB code generated for use in this study is freely
available on the Boulanger lab website (http://www.bou
langerlab.org/).
Frequency of class 1 PDZ ligand motifs in the
extracellular versus cytoplasmic domains
Amino acid sequences for 20 mouse MHCI and MHCI-like
proteins (H2-K, −D, −L, −M1, −M2, −M9, −T3, −T5, −T9,
−T11, −T15, −T22, −T23 (also known as Qa-1), −T24,
−Q1, −Q2, −Q5, HFE, FcRn, and MR1) were obtained from
the NCBI Protein Database (http://www.ncbi.nlm.nih.gov/
protein). Cytoplasmic, transmembrane, and extracellular
domains of each sequence were identified by prediction of
transmembrane position by hydrophobicity (TMHMM;
http://www.cbs.dtu.dk/services/TMHMM/) as well as by
sequence homology with MHCI proteins of known top-
ology. Class 1 PDZ ligand motifs were identified using a
lab-built MATLAB program (see above), and putative PDZ
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ligand frequency was defined as the number of putative
PDZ ligands per 100 amino acids. To generate the baseline
“random” frequency of PDZ ligand motifs for a given se-
quence, each amino acid sequence was scrambled using an
online text scrambler (http://textmechanic.com/Word-
Scrambler.html), and all PDZ ligand motifs identified using
MATLAB. This process was repeated ten times for each se-
quence to generate an estimate of the likelihood of a PDZ
ligand appearing by chance, appropriately weighted by the
amino acid composition of each protein. Randomization
was performed for each MHCI protein individually, and the
values were averaged across genes. For scrambled sequence,
the full amino acid sequence of a given MHCI protein was
randomized and searched for ligands or inverse ligands.
The peptide was then randomized again and searched
again. Ten randomization replicates per protein were per-
formed to obtain an estimate of the average chance of ran-
domly generating putative PDZ ligands from that particular
pool of amino acids. The total number of each motif was
compiled in Excel (Microsoft) and graphed in Origin
(Microcal).
Relative frequencies of specific class 1 and class 2 PDZ
ligand motifs in the cytoplasmic domain
Full length amino acid sequences for 99 MHCI or
MHCI-like proteins from 21 species were obtained using
STRING (see above). Sequences were searched using
custom-designed MATLAB software for the presence of
specific forms of putative class 1 [X (S/T) X (V/L)], class
2 ([XΦXΦ], where Φ = (VILMFWC)), or class 3 [X (D/
E) X Φ] PDZ ligand motifs [51]. The total number of
each specific motif in the extracellular and cytoplasmic
domains of all proteins was complied in Excel (Micro-
soft) and graphed in Origin (Microcal).
Representation of amino acid conservation in logos
The Logos Look Amazing (LOLA) program was used to
visualize amino acid sequence conservation.
LOLA was created by the Bader lab and is freely avail-
able on their lab website (http://baderlab.org/Software/
LOLA) [50].
Cloning of MHCI cytoplasmic domain and expression of
recombinant peptides
All procedures were performed in accordance with pro-
tocols approved by the Princeton University Institutional
Animal Care and Use Committee (IACUC). Mice were
maintained on a 12 h light-dark cycle with food and
water access ad libitum. C57BL/6 mice were obtained
from The Jackson Laboratory (Bar Harbor, ME). Postna-
tal day 14 C57BL/6 mice were deeply anesthetized to a
surgical plane via inhalation anesthesia, decapitated,
their brains rapidly removed, and hippocampi microdis-
sected. Tissue was homogenized via mortar and pestle
and the RNA was extracted and purified using a Qiagen
RNeasy Mini Kit (Valencia, CA). RT-PCR of total RNA
was performed using the Quanta Biosciences qScript
cDNA Synthesis Kit (Gaithersburg, MD). C-terminal se-
quences of the classical MHCI H2-Kb were amplified
using PCR with the primer sequences shown in
Additional file 4: Figure S4A. Restriction sites (BglII and
NcoI) were included flanking each primer, allowing them
to be cloned into the pET29a vector. All MHCI and
PDZ constructs were commercially sequenced (GeneWiz)
to verify correct insertion of the target sequence. After se-
quencing, constructs were subcloned into a pGTK vector
(gift of T. Shenk) via BamHI and HindIII restriction sites
for N-terminal GST tagging, to facilitate purification and
detectection. Site-directed mutagenesis (T329A) was simi-
larly introduced in the pET29a vector, verified by sequen-
cing, and cloned into the pGTK vector.
GST-tagged C-terminal MHCI peptides and 6xHis-
tagged PDZ domain constructs for MAGI-1 and SAP97
(gift of R. Hall) were expressed in BL21(DE3) competent
E. coli (New England Biolabs, Ipswich, MA) using 1.2 L
(MHCI peptides) or 10 ml (PDZ peptides) of Overnight
Express Instant TB Media (EMD Millipore, Billerica,
MA). Cell lysates were applied to columns (equilibrated
glutathione columns (Pierce GST Spin Purification Kit)
for GST-tagged MHCI cytoplasmic domains, or Pierce
HisPur Cobalt Spin Purification columns (0.2 ml resin
bed, Rockland, IL) for 6xHis-tagged PDZ domains) to
bind the expressed peptides, and washed according to
the manufacturer’s protocols. Recombinant proteins
were desalted using Thermo Fisher desalting columns,
following the manufacturer’s protocol, and quantified
using a Pierce BCA Protein Assay kit.
In vitro binding assays
Binding assays were performed as previously described
[70]. Briefly, purified recombinant 6xHis-tagged PDZ
domain peptides were spotted (1 μg of each peptide per
spot; for titration experiments, 5 μg/spot) onto a nitro-
cellulose membrane and dried. Membranes were incu-
bated in blocking buffer (2 % nonfat dry milk, 0.1 %
Tween 20, 50 mM NaCl, 10 mM Hepes, pH 7.4) for 1 h
at RT. Membranes were incubated in GST-tagged re-
combinant MHCI cytoplasmic domain peptides (200
nM, unless otherwise noted, diluted in blocking buffer)
overnight at 4 °C with shaking. Membranes were washed
3×5 min in TBST and then incubated with rabbit anti-
GST primary antibody (1:1000) (Thermo (8–326)) for
1 h at RT. Membranes were washed 5×5 min in TBST
and incubated in HRP-conjugated anti-rabbit secondary
antibody (1:5000; Rockland Immunochemicals, Gillberts-
ville, PA) for 1 h at RT, followed by washing in TBST.
Membranes were treated with West Pico Chemilumines-
cent Substrate (Pierce, Rockland, IL) and exposed on
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HyBlot CL Autoradiography Film (Denville Scientific,
Metuchen, NJ). Densitometry was performed on scanned
Western blots and quantified using the ImageJ 1.32 soft-
ware (National Institutes of Health, Bethesda, MD).
Background measurements were made on the same blot
in areas where no bands or spots were detected, and
these background values were subtracted from density of
the bands of interest to obtain background-subtracted
values.
Competition experiment
GST-tagged C-terminal MHCI peptides were expressed
in BL21(DE3) competent E. coli (New England Biolabs,
Ipswich, MA) using 1.2 L of Overnight Express Instant
TB Media (EMD Millipore, Billerica, MA). Cell lysates
were applied to equilibrated glutathione columns (Pierce
GST Spin Purification Kit) for GST-tagged MHCI cyto-
plasmic domains. Recombinant GST proteins were
desalted using Thermo Fisher desalting columns, follow-
ing the manufacturer’s protocol, and quantified using a
Pierce BCA Protein Assay kit. His-tagged MAGI-1 were
expressed in BL21(DE3) competent E. coli (New England
Biolabs, Ipswich, MA) using 5 mL of Overnight Express
Instant TB Media (EMD Millipore, Billerica, MA). Cell
lysates were bound to HisPur Cobalt Spin Purification
columns (0.2 ml resin bed, Rockland, IL) and incubated
overnight at 4 °C. Columns were washed 3 times accord-
ing to manufacturer’s protocols and preincubated with
respective competitor GST MHCI peptide (GST-H2-T22
or GST-H2-D) at a concentration of 200 nM in manu-
facturer’s wash buffer for 2 h at 4 °C. Following preincu-
bation, 200 nM of GST-H2-K was added to the column
for 2 h at 4 °C. Columns were washed 5 times in manufac-
turer’s wash buffer at 700×g for 2 min, and bound pep-
tides were eluted according to manufacturer’s protocols
(400 μL of elution buffer, overnight incubation, 4 °C).
Samples were prepared as follows: 30 μL of eluate + 10 μL
of 4× sample buffer were boiled for 10 min and run on a
4–20 % gradient gel (BioRad), followed by western blot-
ting (below) to visualize proteins.
Western blotting
To verify the identity of the recombinant GST-tagged
MHCI cytoplasmic domain peptide, 1 μg of purified
GST-H2-Kb was subjected to SDS-PAGE on a 4–20 %
gradient gel (Bio-Rad) and transferred to an Immobilon-
P PVDF transfer membrane (Millipore) as previously de-
scribed [9]. PVDF membranes were blocked overnight at
4 °C in blocking buffer (5 % milk in TBST [20 mM Tris
pH 7.5, 150 mM NaCl, 0.1 % Tween 20]). Primary anti-
bodies (mouse anti-MHCI [p8, 1:5000, purified rabbit
polyclonal raised against exon 8 of H-2K, GeneScript])
were diluted in blocking buffer and incubated with the
membranes overnight at 4 °C. Membranes were washed
for 12×5min in TBST, followed by a 1 h incubation at
RT with HRP-conjugated goat anti-rabbit secondary
antibody (1:20,000; Jackson ImmunoResearch Laborator-
ies # 111:035:144) and washing for 12×5 min in TBST.
Membranes were treated with Pierce ECL Western Blot-
ting Substrate (#32106, Rockland, IL) and exposed on
HyBlot CL Autoradiography Film (Denville Scientific,
Metuchen, NJ). A single strongly-reactive band of the
predicted size for the GST fusion protein (30 kDa) was
detected (Additional file 4: Figure S4C).
For competition experiments, samples were prepared
and run on a SDS-PAGE 4–20 % gradient gel (Bio-Rad)
and transferred to a PVDF membrane (Millipore). Mem-
branes were incubated in an antibody raised against
exon 8, in the cytoplasmic domain of H2-K (P8 (Gene-
Script), 1:5,000 dilution in 5 % organic dry milk),
followed by 12×5 min washes in TBST. Membranes
were then incubated in HRP-conjugated goat anti-rabbit
secondary (1:10,000 dilution) for 1 h at RT, and washed
7×5 min in TBST.
Membranes were incubated in stripping buffer (15 g gly-
cine, 1 g SDS, 10 ml Tween-20, pH 2.2) for 15 min and
washed 3×5mins in TBST. The membranes were blocked
overnight at 4 ° C in 3 % BSA in TBST and re-probed with
anti-HIS antibody (1:5,000 dilution in 3 % BSA; Cell Sig-
naling Technology #2364) overnight at 4 °C. Membranes
were washed 12×5min in TBST and incubated in HRP-
conjugated goat anti-rabbit secondary antibody (1:10,000
dilution) for 1 h at RT and washed 7×5min in TBST. Blots
were treated with ECL as above and used to expose film.
The density of the bands on Western blots (below) was
quantified using ImageJ software and calculated as the ra-
tio of the density of H2-K over the density of HIS-PDZ.
Proteomic sample preparation and MS data acquisition
We performed mass spectrometry on samples that con-
tained high concentrations of the GST-H2-Kb fusion
peptide or the GST-H2-Kb T329A point mutant peptide.
Protein solutions were subjected to buffer exchange into
8 M urea, followed by thiol reduction and alkylation,
and tryptic digestion using the FASP procedure [97].
Peptides were desalted using StageTip micro-scale
reversed-phase C18 chromatography [98] and subjected
to reversed-phase nano-LC-MS and MS/MS on an Orbi-
trap Elite hybrid mass spectrometer (ThermoFisher),
outfitted with an Easy nLC 1000 Ultra nano-UPLC sys-
tem (Proxeon) and a Flex ion source (Proxeon). Sample
concentration and washing was achieved online using a
trapping capillary column (150 μm × ca. 40 mm, packed
with 3 μm, 100 Å Magic AQ C18 resin, Michrom, Au-
burn, CA) at a flow rate of 5 μL/min for ca. 5 min, while
separation was achieved using an extended analytical ca-
pillary column (75 μm × ca. 45 cm, packed with 3 μm,
100 Å Magic AQ C18 resin, Michrom) under a linear
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gradient of A and B solutions (solution A: 3 % aceto-
nitrile/0.1 % formic acid; solution B: 97 % acetonitrile/
0.1 % formic acid) over 180 min at a flow rate of
300 nL/min with column heating at 55 °C. Nano electro-
spray ionization was carried out at 2.4 kV, with the Elite
heated capillary set to 275 °C. Full-scan mass spectra
were acquired in the Orbitrap in positive-ion mode over
the m/z range of 335–1800 at a resolution of 120,000
and the top 15 most abundant multiply charged species
in every full scan were subject to MS/MS. Lockmass lin-
ear recalibration was employed using a siloxane back-
ground ion (m/z 445), which maintained absolute mass
accuracy to within 2–3 ppm.
MS data analysis
Resultant LC-MS/MS data were searched against custom
databases consisting of MHCI fusion protein construct
sequences concatenated to either the UniProt Mouse
proteome or a PDZ-domain-containing protein subset of
the UniProt Mouse proteome, using ProteomeDiscov-
erer (v. 2.1, ThermoFisher Scientific) with the Mascot
search engine node (v. 2.5, Matrix Science, London,
UK.). Search parameters allowed for a mass error of
6 ppm for precursor species and 1.2 Da for fragments, ≤
3 missed trypsin cleavages, methionine oxidation and N-
terminal protein acetylation as variable modifications
and carbamidomethylation of cysteines as a fixed modifi-
cation. Aggregate search results for each sample were
imported into Scaffold software (v. 4.4.8 Proteome Soft-
ware, Portland, OR), for consolidation and visualization.
Additional files
Additional file 1: Figure S1. Categorization of PDZ ligands. The current
study made use of forms of Lenfant et al.’s [44] and Nourry et al.’s [46]
criteria to identify potential PDZ ligand motifs in MHCI proteins. Related
rules were proposed in [45]. (PPTX 35 kb)
Additional file 2: Figure S2. PDZ ligand motifs identified in the
cytoplasmic domains of 16 mouse MHCI and MHCI-like proteins. Putative
PDZ ligand motifs are highlighted in red, and previously noted conserved
serines and tyrosine (see text) are underlined in bold. Consensus motifs:
class 1 PDZ, [S/T X Φ]; class 2 PDZ, [ΦXΦ]; class 3 PDZ, [D/E X Φ]; Φ = Y, F,
W, C, M, V, I, L, or A [44]. H2-T23 is also known as Qa-1. No ligand motifs
were found in the cytoplasmic domain of H2-M2 or -M9, and therefore they
are omitted. Soluble MHCI proteins including H2-Q10 lack a cytoplasmic
domain and were not considered in this analysis. (PPTX 37 kb)
Additional file 3: Figure S3. Frequency of occurrence of specific class
2 and 3 PDZ ligand motifs in the cytoplasmic domains of 99 MHCI
proteins from 21 species. A. Class 2 PDZ ligand motifs ([ΦXΦ], where
Φ = V, I, L, M, F, W, or C), or B. class 3 PDZ ligand motifs ([D/E X Φ) [46])
in the cytoplasmic domains of 99 MHCI proteins from 21 species (data
used to create pie charts in Fig. 2e and f, respectively). Shown are the
number of occurrences of each motif as well as the fraction they
represent of the total motifs observed in each domain. Class 2 PDZ
ligand forms that were never observed in either domain are not shown.
(PPTX 73 kb)
Additional file 4: Figure S4. Molecular validation of tools used in
Fig. 3. A. Sequences of primers used to clone native MHCI cytoplasmic
domains from whole mouse brain, as well as primers used to generate
point mutations and deletions in cloned sequences. pET29a primers were
used to amplify target sequences and introduce point mutations; pGTK
primers were used for subcloning into a vector for N-terminal GST
tagging and subsequent sequencing, purification and detection. B-C.
Confirmation of the amino acid sequence of recombinant H2-K cytoplasmic
peptides employed in binding experiments by MS. Peptide spectral matches
to (B) H2-K and (C) the T329A mutant of H2-K sequences found in the LC-
MS/MS data. Prominent fragment ions are labeled with their b-/y- type ion
designations. Inset into the spectra (above) are sequence fragmentation flag
diagrams summarizing all the detected fragment ions present in the spectra.
The detected mutation sites are highlighted in the sequences in red. D.
Recombinant GST-tagged H2-K peptide is recognized by an antibody raised
against exon 8 of the cytoplasmic domain of H2-K. The immunoreactive
band (arrow) runs at the predicted molecular weight for GST-H2-K
cytoplasmic domain (30 kDa). Numbers, molecular weight in kDa. E.-F.
Titration experiments with increasing concentrations of H2-K cytoplasmic
domain peptides and constant concentrations of MAGI-1-derived peptides.
H2-K cytoplasmic domain binds to MAGI-1 PDZ1 and PDZ3 in a dose-
dependent manner. Bottom row, H2-K peptide spotted directly on the
membrane (positive control). Controls for in vitro binding specificity show
that GST alone shows no specific binding to any PDZ domain from MAGI-1.
F, Densitometry-based quantification of H2-K binding to MAGI-1 PDZ1 for
the experiment shown in E. (PPTX 1995 kb)
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